Balyasny Asset Management’s Monmouth Real Estate Investment Corp MNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-251,293
Closed -$4.69M 2808
2021
Q3
$4.69M Buy
251,293
+160,180
+176% +$3.03M 0.02% 844
2021
Q2
$1.71M Buy
+91,113
New +$1.71M 0.01% 1073
2020
Q4
Sell
-365,971
Closed -$5.07M 1900
2020
Q3
$5.07M Buy
+365,971
New +$5.22M 0.04% 611
2020
Q2
Sell
-13,384
Closed -$161K 1664
2020
Q1
$161K Buy
+13,384
New +$185K ﹤0.01% 1061
2019
Q3
Sell
-125,916
Closed -$1.71M 1813
2019
Q2
$1.71M Sell
125,916
-429,168
-77% -$5.89M 0.01% 926
2019
Q1
$7.32M Buy
+555,084
New +$7.37M 0.05% 471
2018
Q3
Sell
-20,767
Closed -$343K 2295
2018
Q2
$343K Sell
20,767
-68,806
-77% -$1.06M ﹤0.01% 1472
2018
Q1
$1.35M Buy
89,573
+55,707
+164% +$873K 0.01% 1115
2017
Q4
$603K Buy
33,866
+5,663
+20% +$98K ﹤0.01% 1495
2017
Q3
$457K Sell
28,203
-141,349
-83% -$2.21M ﹤0.01% 1385
2017
Q2
$2.55M Buy
+169,552
New +$2.51M 0.01% 890

Other funds holding MNR

Balyasny Asset Management's MNR Position: Q4 2021 in Review

Balyasny Asset Management sold out of Monmouth Real Estate Investment Corp (MNR) in Q4 2021, closing a stake of 251,293 shares — an estimated $4.69M sold.

Balyasny Asset Management first reported a position in MNR in Q2 2017 and held it in 11 quarters. The position peaked at $7.32M in Q1 2019. 238 funds tracked by Wall St. Rank hold MNR as of Q4 2021.

  • Balyasny Asset Management reported no remaining Monmouth Real Estate Investment Corp position as of Q4 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 251,293 Monmouth Real Estate Investment Corp shares in Q4 2021, an estimated $4.69M.
  • Balyasny Asset Management first reported a position in Monmouth Real Estate Investment Corp in Q2 2017 and held it in 11 quarters.
  • Balyasny Asset Management's Monmouth Real Estate Investment Corp position peaked at $7.32M in Q1 2019.
  • 238 funds tracked by Wall St. Rank held Monmouth Real Estate Investment Corp as of Q4 2021.

Based on Balyasny Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.